Portal de Periódicos da CAPES

Secondary immune thrombocytopenia supposedly attributable to COVID-19 vaccination

2021; BMJ; Volume: 14; Issue: 5 Linguagem: Inglês

10.1136/bcr-2021-242220

1757-790X

Omar Fueyo‐Rodríguez, Benjamín Valente-Acosta, Rodolfo Jiménez-Soto, Yvette Neme-Yunes, Sergio I. Inclán-Alarcón, Roxana Trejo-González, Miguel Ángel García Salcido,

Blood groups and transfusion

Immune thrombocytopenia (ITP) has been widely reported as a complication of SARS-CoV-2 infection, but to our knowledge, there have been no reports on the association of the COVID-19 vaccine with thrombocytopenia. Here, we report a case of secondary ITP in a patient who was recently immunised with the messenger RNA COVID-19 vaccine BNT162b2 (Pfizer–BioNTech).